SOPHiA GENETICS SA
SOPH- Exchange
- Nasdaq
- Industry
- Services-Computer Processing & Data Preparation
- SEC CIK
- 0001840706
In the last 90 days, SOPHiA GENETICS SA insiders filed 0 open-market purchases and 35 sales; 71 institutions reported holding it in 13F filings for Q2 2026, worth $212.5M in total; Akre Capital Management is the only superinvestor holding it.
Q4 2022 vs. Q3 2022
How the institutions holding SOPHiA GENETICS SA changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 34 | 32 | −2 |
| Shares | 20.8M | 19.4M | −1.32M (−6.4%) |
| Value | $54.6M | $40.1M | −$14.5M (−26.6%) |
New holders (1)
Institutions that held SOPHiA GENETICS SA at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Federated Hermes, Inc. | 100,000 | $206.0K | 0.00% |
Sold out (3)
Institutions that held SOPHiA GENETICS SA at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| PFM Health Sciences, LP | 879,913 | $2.31M |
| BNP Paribas Arbitrage, SA | 489 | $1.29K |
| Alta Advisers Ltd | 1,000 | – |